Abstract
Resistance to antiestrogen therapy remains a critical determinant of mortality in patients affected by ER+ breast cancer. Our previous work identified autophagy and interferon regulatory factor 1 (IRF1) signaling as key regulators of this process. We have recently demonstrated a novel reciprocal interaction between IRF1 and ATG7, linking inflammation and autophagy.
| Original language | English (US) |
|---|---|
| Article number | e1023928 |
| Journal | Molecular and Cellular Oncology |
| Volume | 3 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2 2016 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2016, © 2016 Taylor & Francis Group, LLC.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- ATG7
- IRF1 tumor suppressor
- autophagy
- breast cancer
- estrogen receptor
- unfolded protein response
Fingerprint
Dive into the research topics of 'Linking autophagy with inflammation through IRF1 signaling in ER+ breast cancer'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS